Ayr Wellness Inc (3KJB.DU)
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Ayr Wellness reported solid first quarter results. Cresco Labs reported stagnant sales but an optimistic outlook for 2024. Tilray announced a $250 million equity offering to fund U.S. asset acquisitions amid legalization optimism. Flora Growth is strategizing on cannabis reform to its reverse financial trend. Key Takeaways; Psychedelic Sector Enveric Biosciences […]
- GlobeNewswire
AYR Wellness Reports First Quarter 2024 Results
Q1 Revenue up 3% Q/Q to $118.0 Million, Excluding Discontinued Operations Q1 GAAP Loss from Operations Improved to $2.0 Million, Excluding Discontinued Operations Q1 Adjusted EBITDA1 up over 10% Y/Y to $29.1 Million, with Adjusted EBITDA Margin of 25% Company generated free cash flow for the quarter and expects to for FY2024 MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis oper
- Zacks
Ayr Wellness Inc. (AYRWF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ayr Wellness Inc. (AYRWF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
